Publication: 4265

Alliance A071401: Phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations
         Google Scholar   
Citation:
J Clin Oncol vol 24 (suppl 16) 2001
Meeting Instance:
ASCO 2024
Year:
2024
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Primary
Analysis:
Preliminary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
4575  
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
Eli Lily  
Grants:
U10CA180821, U10CA180882, UG1CA189867 (NRG)  
Corr. Author:
 
Authors:
                                         
Networks:
COLUMBIA, CRCWM, IA018, LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-NH012, LAPS-NY016, LAPS-PA015, NC002, VA002   
Study
Alliance-A071401
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: